These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 11487614
1. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D. J Neurosci; 2001 Aug 15; 21(16):5916-24. PubMed ID: 11487614 [Abstract] [Full Text] [Related]
2. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA. J Neurochem; 2003 May 15; 85(4):898-910. PubMed ID: 12716422 [Abstract] [Full Text] [Related]
3. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. J Neurosci; 1998 Mar 15; 18(6):1979-86. PubMed ID: 9482784 [Abstract] [Full Text] [Related]
4. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr 15; 237(1):193-203. PubMed ID: 3007738 [Abstract] [Full Text] [Related]
5. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr 15; 237(1):179-92. PubMed ID: 3007736 [Abstract] [Full Text] [Related]
7. Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein. Chadchankar H, Yavich L. Brain Res; 2011 Nov 14; 1423():67-76. PubMed ID: 22000591 [Abstract] [Full Text] [Related]
8. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. L'hirondel M, Chéramy A, Godeheu G, Artaud F, Saiardi A, Borrelli E, Glowinski J. Brain Res; 1998 May 11; 792(2):253-62. PubMed ID: 9593923 [Abstract] [Full Text] [Related]
9. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR. J Neurochem; 1999 Jan 11; 72(1):148-56. PubMed ID: 9886065 [Abstract] [Full Text] [Related]
10. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. J Biol Chem; 2003 Apr 04; 278(14):12070-7. PubMed ID: 12556446 [Abstract] [Full Text] [Related]
11. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. Chen BT, Rice ME. J Neurosci; 2001 Oct 01; 21(19):7841-7. PubMed ID: 11567075 [Abstract] [Full Text] [Related]
12. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. Schmitz Y, Schmauss C, Sulzer D. J Neurosci; 2002 Sep 15; 22(18):8002-9. PubMed ID: 12223553 [Abstract] [Full Text] [Related]
13. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. Wu Q, Reith ME, Walker QD, Kuhn CM, Carroll FI, Garris PA. J Neurosci; 2002 Jul 15; 22(14):6272-81. PubMed ID: 12122086 [Abstract] [Full Text] [Related]
14. Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. Fawaz CS, Martel P, Leo D, Trudeau LE. BMC Neurosci; 2009 Aug 14; 10():96. PubMed ID: 19682375 [Abstract] [Full Text] [Related]
15. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. O'Dell SJ, Weihmuller FB, Marshall JF. J Neurochem; 1993 May 14; 60(5):1792-9. PubMed ID: 8473897 [Abstract] [Full Text] [Related]
16. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake. Cass WA, Larson G, Fitzpatrick FA, Zahniser NR. J Pharmacol Exp Ther; 1991 Jun 14; 257(3):990-6. PubMed ID: 1828506 [Abstract] [Full Text] [Related]
17. Differential action of (+)-amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens. Wieczorek WJ, Kruk ZL. Br J Pharmacol; 1994 Mar 14; 111(3):829-36. PubMed ID: 8019759 [Abstract] [Full Text] [Related]
18. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A. Proc Natl Acad Sci U S A; 2000 Jun 06; 97(12):6850-5. PubMed ID: 10823899 [Abstract] [Full Text] [Related]
19. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Centonze D, Picconi B, Baunez C, Borrelli E, Pisani A, Bernardi G, Calabresi P. Neuropsychopharmacology; 2002 Feb 06; 26(2):164-75. PubMed ID: 11790512 [Abstract] [Full Text] [Related]
20. Biphasic mechanisms of amphetamine action at the dopamine terminal. Siciliano CA, Calipari ES, Ferris MJ, Jones SR. J Neurosci; 2014 Apr 16; 34(16):5575-82. PubMed ID: 24741047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]